Ketamine for alcoholism

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 May 2018: Trial started, NCT03539887
  2. 29 May 2018: Trial registered, NCT03539887

The trials

NCT03539887: Trial of the Rapid Antisuicidal Effects of Intranasal Ketamine in Comorbid Depression and Alcohol Abuse

State
Completed
Phase
Phase 3
People
33 taking part
Started
1 May 2018
Primary completion
15 Jan 2022
Arms
Intranasal ketamine
Results
Posted on the registry
  1. 1 May 2018: Trial started
  2. 29 May 2018: Trial registered
  3. 15 Jan 2022: Trial completed
  4. 1 Mar 2023: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as 0.2 mg/kg ketamine, 1st perfusion of ketamine, 2nd perfusion of ketamine, Anaket v, Calypsol, CLORKETAM 1000, IMALGENE 1000, Intranasal Ketamine (IN), Intranasal ketamine, Ketafol component ketamine, KETASOL 100, Ketamine Infusion, Narketan, Tekam, Ursotamin, Vetaket.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.